Access to Biomarker Testing Press Releases

March 13, 2024

Cancer Advocates Urge Colorado Legislators to Take Critical Step to Connect Patients with Most Effective Treatment Options

DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure  biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.

February 22, 2024

State Legislator Honored for Opening Door to Precision Medicine and Targeted Therapies

SANTA FE, NEW MEX. – February 22, 2024 – State Representative Joy Garratt was honored with the ‘Legislative Champion Award’ by the American Cancer Society Cancer Action Network (ACS CAN)  during a luncheon, Thursday. This award is the highest honor given by the organization. Garratt was recognized for her leading role in expanding access to biomarker testing in New Mexico. She served as a lead sponsor for HB 73 during the 2023 legislative session. 

February 22, 2024

New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes

A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and creating disparities that impact diverse populations.

February 6, 2024

Senate Votes to Remove Barriers to Precision Treatments

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state